David R. Walt, Tufts University
University Professor at Tufts University and is a Howard Hughes Medical Institute Professor. Dr. Walt is the Scientific Founder of both Illumina Inc. and Quanterix Corp and several other companies. He is a member of the National Academy of Engineering.
Jay Flatley, Illumina
Jay Flatley is Executive Chairman of Illumina. He served as President and CEO from 1999 to early 2016, and took the company from $1.3 million in sales in 2000 to over $2.2 billion in 2015. Jay also serves as Chairman of the Board of Helix and Grail.
Jim Goldberg, Counsyl
Dr. Goldberg is currently the Chief Medical Officer at Counsyl. He is board certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics. He has served as president of the Perinatal Quality Foundation and on the board of the Society for Maternal Fetal Medicine.
Daniel S. Grosu, LabCorp
Daniel S. Grosu has more than 15 years of experience in the Diagnostics space. He was most recently the Chief Medical Officer at Sequenom. Previously, Dr. Grosu served as Illumina’s first Chief Medical Officer; he established the Clinical Development and Medical Affairs functions at Illumina, and led the team that performed the clinical studies supporting the first FDA clearance and first CE Marking of a next-generation sequencing IVD platform and clinical assay. Earlier in his career, Dr. Grosu held positions of increasing responsibility at Siemens Medical Solutions, Bayer HealthCare Pharmaceuticals, and Johnson & Johnson. Dr. Grosu holds an MD (with Distinction in Research) from Saint Louis University School of Medicine, Missouri, and an MBA from the University of Oxford, UK.
Alex Aravanis, GRAIL
Alex Aravanis heads the research and development group at GRAIL, an Illumina spin-out company based in the San Francisco Bay Area, United States. GRAIL is focused on the development of an early cancer detection test based on deep sequencing of cell-free nucleic acids. Prior to GRAIL, Alex developed multiple products at Illumina, including clinical assays for the analysis of RNA and DNA from fixed tissues, whole exome analysis, massively parallel single cell transcriptomics, and liquid biopsy using cell-free nucleic acids. He received his MD and PhD in electrical engineering from Stanford University.